OZ Biosciences
PrivateLast Round
Grant
Jan 1, 2020
Total Funding Raised
$16.79M
Company Overview
OZ Biosciences operates in Healthcare & Life Sciences and is based in Marseille. Its latest recorded funding round was a Grant round in January 2020.
OZ Biosciences is a life sciences company that develops and produces molecular delivery systems designed for transfection and transduction.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OZ Biosciences Comparables
Compare OZ Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rockland Immunochemicals | 81% | |
| Sartorius Aktiengesellschaft | 78% | |
| Merck | 76% |
For institutional investors. Book with your work email.
OZ Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2020 | ||||
| Grant | Nov 1, 2016 | ||||
| Grant | Oct 1, 2013 | ||||
| Grant | Jan 1, 2010 | ||||
| Grant | Apr 1, 2006 | ||||
Grant | Jan 1, 2006 |
For institutional investors. Book with your work email.
OZ Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| European Commission | Grant |
| EU FP7 Programme | Grant |
| Incubateur Impulse | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
Monthly visitors grew 136% MoM, reaching 20.6K.
- May 2, 2025
Monthly visitors grew 49% MoM, reaching 11.3K.
For institutional investors. Book with your work email.
OZ Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about OZ Biosciences's valuation, stock price, and market status.
Is OZ Biosciences a public or private company?
OZ Biosciences is a private company.
What is the current stock price of OZ Biosciences?
OZ Biosciences is a private company, so its shares have no public market price. Caplight tracks OZ Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is OZ Biosciences worth (valuation)?
Valuation information for OZ Biosciences is not publicly available.
Can I buy OZ Biosciences stock?
OZ Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was OZ Biosciences's last funding round?
OZ Biosciences's most recent funding round was Grant on January 1, 2020.
Who are the main investors in OZ Biosciences?
Key investors in OZ Biosciences include European Union's Horizon Research and Innovation program, European Commission, EU FP7 Programme, Incubateur Impulse.
Will OZ Biosciences IPO soon?
No public IPO plans have been announced for OZ Biosciences.
How can I track OZ Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in OZ Biosciences's shares on secondary markets.